◆英語タイトル：
Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019
◆商品コード：FMI609211
◆発行会社（リサーチ会社）：
Future Market Insights
◆発行日：2016年8月8日
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション
（消費税別）
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。
| ※本調査レポートでは、再生医療の世界市場について調査・分析し、市場概観、再生医療の世界市場規模、市場規模予測、地域別分析（アメリカ、ヨーロッパ、アジア等）、セグメント別市場分析、競争状況、再生医療市場動向、関連企業分析などを含め、以下の構成でお届けいたします。 |
【レポートの概要】
REPORT DESCRIPTION
This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs.
The research is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2019, considering the macro and micro environmental factors. Growth rates for each segment within the global regenerative medicine market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global regenerative medicine market with respect to market segments based on the technology type, application type and geographic analysis. This report includes estimation of the global regenerative medicine (bone and joint) market in terms of value (USD million) for the period 2015 to 2019. In addition, current trends and recent developments are taken into consideration while determining the growth rate of the global regenerative medicine (bone and joint) market. The report provides market size and forecast for each segment, sub-segment and geographic region with CAGR % for the period 2015 to 2019.
The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. However, high cost associated with biomaterials is a factor that would restrict the global market demand to some extent during the study period.
In addition, based on applications the global market for regenerative medicine (bone and joint) is segmented as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. However, post implantation rejection associated with bone graft substitute is considered as a crucial factor that would restrict the global market demand of bone graft substitute.
Geographically, the global regenerative medicine (bone and joint) market has been segmented into four regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). Market size, forecast and CAGR (%) for each region have been provided. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the regenerative medicine (bone and joint) market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has also been discussed in the study that is expected to help in decision-making.
Major market players profiled in this report includes Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc.
The global regenerative medicine (bone and joint) market is segmented as follows:
Regenerative Medicine (Bone and Joint) Market, by Technology
Stem Cell Therapy
Biomaterial
Tissue Engineering
Regenerative Medicine (Bone and Joint) Market, by Application
Bone Graft Substitutes
Osteoarticular Diseases
Allogeneic Bones
Autogenic Bones
Others
Regenerative Medicine (Bone and Joint) Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World
Table Of Content
1. Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
1.4 List of Abbreviations
2. Executive Summary
2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2015 & 2019)
2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2015 (US$ Mn)
2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 and 2019 (Value %)
3. Market Overview
3.1 Overview
3.2 Market Drivers
3.3 Restraints
3.4 Opportunities
3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Competitive rivalry
3.6 Competitive Landscape
3.6.1 Market Share Analysis by Key Players, 2012 (Value %)
3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography
4. Regenerative Medicine (Bone and Joint) Market, by Technology
4.1 Introduction
4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (US$ Mn)
4.2 Stem Cell Therapy
4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (US$ Mn)
4.3 Biomaterials
4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (US$ Mn)
4.4 Tissue Engineering
4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (US$ Mn)
5. Regenerative Medicine (Bone and Joint) Market, by Applications
5.1 Overview
5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (US$ Mn)
5.2 Bone Graft Substitutes
5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (US$ Mn)
5.3 Osteoarticular Diseases
5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (US$ Mn)
5.4 Allogeneic Bones
5.4.1 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (US$ Mn)
5.5 Autogenic Bones
5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (US$ Mn)
5.6 Others
5.6.1 Global Others Application Market Revenue, 2011 – 2019 (US$ Mn)
6. Regenerative Medicine (Bone and Joint) Market, by Geography
6.1 Overview
6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (US$ Mn)
6.2 North America
6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)
6.3 Europe
6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)
6.5 Rest of the World (RoW)
6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)
7. Recommendations
7.1 Market Strategy for Success
7.1.1 Rigorous research and development initiatives for innovative products
7.1.2 Investing in emerging economies
7.2 Barriers and Future Assumptions
7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth
8. Company Profiles
8.1 Anika Therapeutics, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.4.1 Distribution agreements for business expansion
8.1.5 Recent Developments
8.2 Arthrex, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.4.1 Mergers and acquisitions for business expansion
8.2.4.2 Distribution agreement for market penetration
8.2.5 Recent Developments
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.4.1 Acquisition for business expansion
8.3.4.2 Public-private partnership for market penetration
8.3.4.3 New product development
8.3.5 Recent Developments
8.4 CONMED Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.4.1 Merger and acquisition for business expansion
8.4.5 Recent Developments
8.5 DePuy Synthes, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.4.1 Extensive research and development activities
8.5.4.2 Relationship with healthcare professionals
8.5.5 Recent Developments
8.6 Medtronic, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.4.1 Strategic partnership and acquisition
8.6.5 Recent Developments
8.7 Smith & Nephew plc
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.4.1 Mergers and acquisitions for business expansion
8.7.4.2 Distribution strategies for market penetration
8.7.5 Recent Developments
8.8 Stryker Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.4.1 Focus on R&D activities
8.8.4.2 Acquisitions for market penetration
8.8.5 Recent Developments
8.9 Zimmer Holdings, Inc.
8.9.1 Business Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.4.1 Mergers and acquisitions for business expansion
8.9.5 Recent Developments
【レポートのキーワード】
再生医療
【免責事項】http://www.globalresearch.jp/disclaimer
